Literature DB >> 24031914

A prospective study on Aeromonas in outpatients with diarrhea in the central region of Rio Grande do Sul State.

Karoline Decampos Prediger1, Renata da Silva Pereira, Carlos Hugo Del Priore Winckler Neto, Roberto Christ Vianna Santos, Cyntia Maria Telles Fadel-Picheth, Bruno Stefanello Vizzotto.   

Abstract

Aeromonas spp. were identified in five (2,7%) of 182 diarrheal stool cultures, A. caviae was predominant, resistant mainly to ampicillin and cephalotin. This is the first study showing the presence of Aeromonas spp. in diarrheal stools of outpatients in the central region of Rio Grande do Sul State, Brazil.

Entities:  

Keywords:  Aeromonas; multi-resistance; outpatients; stools

Year:  2012        PMID: 24031914      PMCID: PMC3768890          DOI: 10.1590/S1517-838220120003000017

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


The diarrheal disease of infectious origin is considered a great epidemic, being registered 1.8 to 2.5 million deaths annually, representing 20% of all deaths among children in developing countries (9). Several microorganisms may be responsible for these infections, Aeromonas spp. is one of the notorious causative agent of diarrhea, as well as extraintestinal infections such as cellulitis, wound infections, sepsis, urinary tract infections, among others (6, 13, 14, 17, 18). The gastroenteritis caused by Aeromonas spp. vary from acute watery diarrhea, dysentery-like and bloody to chronic diarrhea, affecting mainly children and elderly, being the severity of the disease directly related to virulence factors of the strain and the immune status of the patient (4, 5, 18). Belonging to the family Aeromonadacea, Aeromonas spp. are widely distributed in nature, especially in aquatic environment (9), and are transmitted to humans mainly by water and food contaminated with the bacteria. In Brazil there are few studies on Aeromonas frequency in diarrheal diseases (6, 7, 11, 14, 15), and the bacteria is not searched in the routine of most of clinical laboratories. The present study aimed to detect the presence of Aeromonas spp. in stools of outpatients with diarrhea attended by clinical laboratories in Santa Maria/RS, motivated by low number of studies regarding this pathogen in the region. Were analyzed 182 diarrheal stool samples collected in the period of June/2010 to May/2011. The samples were inoculated in Alkaline Peptone Water (Himedia, Mumbai, India) and incubated for 24 hours at 25°C. Then, an aliquot of the culture was inoculated in Nutrient Agar (Himedia, Mumbai, India) and incubated for 24 hours at 37°C. Four isolated colonies of each culture were analyzed by Gram staining and cytochrome oxidase test (Laborclin, Porto Alegre, RS, Brazil) (15). Suspect colonies, i.e. gram-negative bacilli cytochrome oxidase positive, were tested for reactions used for Aeromonas spp. identification: production of catalase, arginine dihidrolase, lysine and ornithine decarboxylase, citrate, production of gas from glucose, fermentation of D-adonitol, L-arabinose, L-dextrose, L-dulcitol, m-inositol, lactose, D-mannitol, mannose, raffinose, L-rhamnose, D-sorbitol, sucrose and D-trehalose, production of indole, motility, Voges-Proskauer and aesculin hydrolysis (1). The antimicrobial susceptibility test was realized by disk diffusion method (3), with the following antimicrobials (Laborclin, Porto Alegre, RS, Brazil): nalidixic acid (30 µg), amoxacillin/clavulanic acid (20/10 µg), ampicillin (10 µg), amikacin (30 µg), aztreonam (30 µg), cephalothin (30 µg,), cefazolin (30 µg), cefepime (30 µg), cefotaxime (30 µg), cefoxitin (30 µg), ceftazidime (30 µg), ceftriaxone (30 µg), ciprofloxacin (5 µg), chloranphenicol (30 µg), gentamicin (10 µg), imipenem (10 µg), trimethoprim-sulfamethoxazole (25 µg), tobramycin (10 µg) and tetracycline (30 µg). This study was approved by the Ethics Committee of our University (CEP/UNIFRA) under registration no. 043.2011.2. The presence of Aeromonas spp. was confirmed in 2.7% (5/182) of the samples, with the predominance of A. caviae (4/5), followed by A. hydrophila (1/5) (Table 1). The prevalence was similar to that related by Surek et al. (15) who found 2.6% of Aeromonas spp. among people with diarrhea in Paraná State, also in Southern Brazil, and other studies made in different regions of the country; in all of them A. caviae was also the most prevalent species (7, 11, 14). However our data are in disagreement with those described by Guerra et al. (6) which found a frequency of 6.6% of Aeromonas spp. in Rio Grande do Sul State and A. hydrophila as the most prevalent species. These differences may be due to the kind of sample studied: while ours included only outpatients, those analyzed by Guerra et al. (6) was composed by inpatients, what also may explain the predominance of A. hydrophila. Regarding the antimicrobial susceptibility test , all strains showed resistance to ampicillin and cephalothin, what is in agreement with the fact that species of Aeromonas are intrinsically resistant to ampicillin (with the exception of A. trota) and cephalothin (with the exception of A. veronii biovar sobria) (1, 6). Among the other antimicrobials tested, resistance to amoxicillin/clavulanic acid was the most common, followed by cefazolin. In total resistance was found to 9 of the 19 antimicrobials tested. Three strains (LOC-02, LOC-81 and LP-1) were multi-resistant (Table 1). These data together suggests that the resistance of Aeromonas should be monitorated.
Table 1

Characterization of Aeromonas spp. isolated from stool samples of outpatients.

SamplesAge1Species2Susceptibility Profile3
LOC-026mA. caviaeAMPR; CFLR; CFZR; CFOI; CLOR
LOC-81NIA. hydrophilaAMPR; CFLR; CFZI; AMCR; AZTI
LOC-12170yA. caviaeAMPR; CFLR; AMCR
LP-1NIA. caviaeAMPR; CFLR; CFZR; AMCR; TETI; SXTR
LP-15NIA. caviaeAMPR; CFLR; TETR

NI: Not informed; y: years; m: months.

Biochemical identification as Janda and Abbott (8)

AMC: Amoxicillin/clavulanic acid; AMP: ampicillin; AZT: Aztreonam; CFL: Cephalothin; CFZ: Cefazolin; CFO: Cefoxitin; CLO: Chloramphenicol; TET; Tetracycline; SXT: trimethoprim/sulfamethoxazole. R: Resistant; I: Intermediate.

Characterization of Aeromonas spp. isolated from stool samples of outpatients. NI: Not informed; y: years; m: months. Biochemical identification as Janda and Abbott (8) AMC: Amoxicillin/clavulanic acid; AMP: ampicillin; AZT: Aztreonam; CFL: Cephalothin; CFZ: Cefazolin; CFO: Cefoxitin; CLO: Chloramphenicol; TET; Tetracycline; SXT: trimethoprim/sulfamethoxazole. R: Resistant; I: Intermediate. This study demonstrated, in a pioneer way, the prevalence of Aeromonas spp. in stools of outpatients with diarrhea in the central region of Rio Grande do Sul State, Brazil. The frequency found is similar to those related for some other enteric pathogens (2, 10, 12, 16) emphasizing the importance of its research by clinical laboratories in the region.
  14 in total

Review 1.  The role of Aeromonas in diarrhea: a review.

Authors:  A von Graevenitz
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

2.  The genus Aeromonas: biochemical characteristics, atypical reactions, and phenotypic identification schemes.

Authors:  Sharon L Abbott; Wendy K W Cheung; J Michael Janda
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 3.  Aeromonas spp. clinical microbiology and disease.

Authors:  Jennifer L Parker; Jonathan G Shaw
Journal:  J Infect       Date:  2010-12-14       Impact factor: 6.072

4.  [The prevalence of Aeromonas spp. in the diarrheal feces of children under the age of 5 years in the city of Goiânia, Goiás in the 1995-1996 biennium].

Authors:  I T Nojimoto; C S Bezana; C do Carmo; L M Valadão; K de M Carrijo
Journal:  Rev Soc Bras Med Trop       Date:  1997 Sep-Oct       Impact factor: 1.581

5.  Etiology of diarrheal infections in children of Porto Velho (Rondonia, Western Amazon region, Brazil).

Authors:  P P Orlandi; G F Magalhães; N B Matos; T Silva; M Penatti; P A Nogueira; L H Pereira da Silva
Journal:  Braz J Med Biol Res       Date:  2006-04-03       Impact factor: 2.590

6.  Aeromonas caviae septicemia in immunocompetent gastrointestinal carriers.

Authors:  M Dwivedi; A Mishra; A Prasad; A Azim; R K Singh; A K Baronia; K N Prasad; U N Dwivedi
Journal:  Braz J Infect Dis       Date:  2008-12       Impact factor: 1.949

7.  [Characterization of Aeromonas spp isolates from newborns hospitalized].

Authors:  Christiane Soares Pereira; Simone Duarte Amorim; André Felipe das Mercês Santos; Cristhiane Moura Falavina Dos Reis; Grace Nazareth Diogo Theophilo; Dália Dos Prazeres Rodrigues
Journal:  Rev Soc Bras Med Trop       Date:  2008 Mar-Apr       Impact factor: 1.581

Review 8.  Aeromonas-associated infections in developing countries.

Authors:  Khalifa Sifaw Ghenghesh; Salwa F Ahmed; Rania Abdel El-Khalek; Atef Al-Gendy; John Klena
Journal:  J Infect Dev Ctries       Date:  2008-04-01       Impact factor: 0.968

9.  Human bocavirus infection in children with gastroenteritis, Brazil.

Authors:  Maria Carolina M Albuquerque; Ludmila N Rocha; Fabrício José Benati; Caroline C Soares; Adriana G Maranhão; Maria Liz Ramírez; Dean Erdman; Norma Santos
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

10.  Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance.

Authors:  Jordi Vila; Joaquin Ruiz; Francisco Gallardo; Martha Vargas; Lara Soler; Maria José Figueras; Joaquin Gascon
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  1 in total

1.  Epidemiological patterns and antimicrobial resistance of bacterial diarrhea among children in Nairobi City, Kenya.

Authors:  Mark Kilongosi Webale; Christine Wanjala; Bernard Guyah; Nathan Shaviya; Godwil O Munyekenye; Peter Lokamar Nyanga; Immaculate Nyaseba Marwa; Sammy Kagoiyo; Laura Nyawira Wangai; Sella K Webale; Kenny Kamau; Nicholas Kitungulu
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.